Uncategorized - August 13, 2014
New findings on gut bacteria can lead to new antibiotics
Recent discovery at the Technical University of Denmark on gut bacteria could lead to the development of new antibiotics and give better understanding of diseases and conditions. 500 previously unknown gut bacteria and more than 800 bacteriophages that have previously been unknown have been mapped by the scientists, meaning that all intestinal bacteria are now mapped. The study […]
Regulatory compliance - August 12, 2014
NeuroSearch convicted for share price manipulation
NeuroSearch has been convicted for share price manipulation in Denmark. On August 8, the company was convicted in an action brought by the Danish State Prosecutor for Serious Economic and International Crime claiming that NeuroSearch was guilty of share price manipulation contrary to the rules of the Danish Securities Trading Act. NeuroSearch has now been ordered to […]
Drug Development Pharma - August 12, 2014
Kancera gets additional funding
Research company Kancera has received a final grant to one of the company’s cancer projects. The grant is given by the Swedish innovation authority Vinnova which has identified Kancera as a young innovative company with growth potential. The company develops new treatment methods for cancer and their ROR project has been allocated another SEK 500 […]
In a new job - August 12, 2014
Nexstim gets new Chief Financial Officer
Finnish Navigated Brain Stimulation company Nexstim has appointed Mikko Karvinen as its new Chief Financial Officer effective as of 18 August. According to Nexstim, Mikko Karvinen, aged 37, started his career as a financial analyst at OP Bank Group, Vaisala Oyj (in Boston and Boulder, USA) and Automaster Oy and in 2009 he was appointed CFO at SSH Communications Security […]
Global report - August 11, 2014
Pfizer faces legal threat over Lipitor
Cases of women claiming Lipitor gave them diabetes is increasing. In 2012, lawsuits concerning Pfizer’s cholesterol fighter Lipitor began as the FDA announced a warning that statins, a type of cholesterol lowering medicines, could have negative effects on memory and could also give a slightly increased risk of developing type 2 diabetes. The number of […]
In a new job - August 11, 2014
Medivir gets new CEO
The company’s Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014. Prager will succeed Maris Hartmanis who now leaves the position of President and CEO of Medivir. Niklas Prager holds a Degree of Master of Science in Business Administration and Economics from the Stockholm School […]
